白介素26(IL26)重組蛋白
Recombinant Interleukin 26 (IL26)
AK155
- 編號URPB695Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預測分子量40.5kDa
- 實際分子量41kDa(差異分析請參閱說明書)
- 片段與標簽Lys24~His112 with N-terminal His and GST Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 95%
- 等電點9.8
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 552 ¥ 1380 ¥ 2760 ¥ 8280 ¥ 20700
- 欲了解實際交易價格和更多情況，請與當地經銷商聯(lián)系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質量體系認證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| UAPB695Hu01 | 白介素26(IL26)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPB695Hu01 | 白介素26(IL26)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB695Hu01 | 白介素26(IL26)多克隆抗體 | WB; IHC; ICC; IP. |
| UMAB695Hu22 | 白介素26(IL26)單克隆抗體 | WB; IHC; ICC; IP. |
| USEB695Hu | 白介素26(IL26)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCB695Hu | 白介素26(IL26)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMB695Hu | 白介素26(IL26)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Journal of Neuroimmunology | Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon beta-1 therapy [PubMed: 23177721] |
| Journal of molecular medicine (Berlin, Germany) | IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA. [pubmed:28879509] |
| The Journal of investigative dermatology | Increased interleukin-26 expression promotes Th17 and Th2-associated cytokine production by keratinocytes in atopic dermatitis [Pubmed: 31465744] |
| Nature Communications | Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway [Pubmed: 32041953] |
| METHOD OF MANUFACTURING BISPECIFIC ANTIBODIES, BISPECIFIC ANTIBODIES AND THERAPEUTIC USE OF SUCH ANTIBODIES [] | |
| Theranostics | IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer [33456560] |
留言咨詢
